Online citations, reference lists, and bibliographies.
← Back to Search

Liver-targeted Gene Transfer Into A Human Hepatoblastoma Cell Line And In Vivo By Sterylglucoside-containing Cationic Liposomes

S. Hwang, K. Hayashi, K. Takayama, Y. Maitani
Published 2001 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We investigated the transfection efficiency of β-sitosterol β-D-glucoside (Sit-G)-containing liposome/DNA complex (Sit-G-liposome/DNA complex) for liver targeting. The Sit-G-liposome/DNA complex was composed of Tfx-20 reagent (Tfx), ie synthetic cationic lipid [N,N,N′,N′-tetramethyl-N,N′-bis(2-hydroxyethyl)-2,3-di(oleoyloxy)-1,4-butanediammonium iodide] with L-dioleoylphosphatidylethanolamine (DOPE), 3β[N-(N′,N′-dimethylaminoethane)-carbamoyl]cholesterol (DC-Chol) and Sit-G with plasmid DNA. The in vitro studies were performed in HepG2 cells in serum-containing medium and the in vivo studies were carried out in the mice following intravenous injection. The Sit-G-liposome produced a Sit-G-liposome/DNA complex of relatively small size (100–250 nm). Transfection efficiency of the luciferase marker gene by Sit-G-liposome/DNA complex was increased in the presence of 10% serum in vitro, and was selectively high in the mouse liver reaching expression values up to an average of 14.9 pg luciferase/mg tissue protein, compared with Tfx/DNA complex, which showed approximately three-fold higher gene expression than Sit-G-liposome/DNA complex in vitro. High in vitro transfection efficiency by Sit-G-liposome/DNA complex seemed to be possible even with large lipid precipitates, whereas high in vivo activity seemed to be related to small and dispersed complexes. The interaction of liposome/DNA complexes with serum may be a key point to predict the in vivo efficiency of a liposome vector.
This paper references
10.1016/S0005-2736(99)00238-2
Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum.
S. Simões (2000)
Receptor-mediated gene delivery and expression in vivo.
G. Wu (1988)
10.1038/sj.gt.3300482
In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes
S. Li (1997)
10.1016/S0168-3659(01)00411-4
Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Y. Maitani (2001)
10.1016/0378-1119(95)00100-K
Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
T. Hara (1995)
10.3109/10611869608995626
Evaluation of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture for liver targeting.
K. Shimizu (1996)
10.1021/JS9504494
Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach.
G. Osaka (1996)
10.1016/0006-291X(91)91366-K
A novel cationic liposome reagent for efficient transfection of mammalian cells.
X. Gao (1991)
10.1248/BPB.20.881
Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.
K. Shimizu (1997)
10.1248/BPB.21.741
Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
K. Shimizu (1998)
10.1089/HUM.1997.8.13-1585
Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration.
Y. Song (1997)
Gene therapy for cystic fibrosis: a clinical perspective.
E. Alton (1995)
10.1016/S0005-2760(97)00169-0
Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells.
O. Zelphati (1998)
10.1038/NBT0797-647
Improved DNA: liposome complexes for increased systemic delivery and gene expression
Nancy Smyth Templeton (1997)
10.1016/0005-2736(95)00205-7
Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
T. Hara (1996)
10.1021/BC980017V
Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
Y. Choi (1998)
10.1073/PNAS.92.5.1744
Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.
J. S. Rémy (1995)
10.1016/S1357-4310(95)80030-1
Non-viral gene therapy.
D. Treco (1995)
Physicochemical characteristics and transfection efficiency of DNA in cationic and neutral liposomes with soybean-derived sterylglucoside into HepG2 cells
Y Maitani (2001)
10.1081/LPR-100103174
MODIFIED ETHANOL INJECTION METHOD FOR LIPOSOMES CONTAINING β-SITOSTEROL β-D-GLUCOSIDE
Y. Maitani (2001)
10.1016/S0165-0270(97)00207-0
Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector
A. Brooks (1998)
10.1073/PNAS.90.23.11307
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
G. Nabel (1993)
10.1002/HEP.510270319
Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents
J. Wu (1998)
Physicochemical Characteristics and Transfection Efficiency of DNA in Liposomes with Soybean-Derived Sterylglucoside into HepG2 Cells
Y. Maitani (2001)
10.1016/0005-2736(95)00238-3
Genistein inhibition of fast Na+ current in uterine leiomyosarcoma cells is independent of tyrosine kinase inhibition.
M. Kusaka (1996)
10.1016/0014-5793(94)01315-2
New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopy
B. Sternberg (1994)
10.1016/S0014-5793(96)01397-X
Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery
K. Hong (1997)
10.1126/SCIENCE.7687073
Systemic gene expression after intravenous DNA delivery into adult mice.
N. Zhu (1993)



This paper is referenced by
10.1006/MTHE.2002.0598
CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo.
N. Yew (2002)
10.1248/BPB.29.1986
Intracellular trafficking is the important process that determines the optimal charge ratio on transfection by galactosylated lipoplex in HEPG2 cells.
Yasunori Saito (2006)
10.1038/sj.gt.3301833
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
J. Reddy (2002)
10.2147/IJN.S2263
Nano-vectors for efficient liver specific gene transfer
A. Pathak (2008)
10.1016/S0378-5173(02)00194-1
Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy.
C. Dass (2002)
10.1016/J.JCONREL.2006.11.006
Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Y. Zhang (2007)
10.1002/3527600906.MCB.200500030
Vector System: Plasmid DNA
Rajkumar Banerjee (2006)
10.1016/j.chemphyslip.2014.10.003
Carbohydrate mediated drug delivery: synthesis and characterization of new lipid-conjugates.
M. Ahmad (2015)
10.1016/j.biomaterials.2008.12.074
Cationic glycolipids with cyclic and open galactose head groups for the selective targeting of genes to mouse liver.
Rajesh Mukthavaram (2009)
10.1109/MHS.2014.7006070
Development of a single cell electroporation method using a scanning ion conductance microscope with a theta type probe pipette
S. Sakurai (2014)
10.1111/j.1747-0285.2012.01446.x
Novel Targeted Liposomes Deliver siRNA to Hepatocellular Carcinoma Cells in vitro
Shantal Dorasamy (2012)
10.1080/15227950290097598
A Novel Cationic Cholesterol Derivative, Its Formulation into Liposomes, and the Efficient Transfection of the Transformed Human Cell Lines HepG2 and HeLa
N. Kisoon (2002)
Novel cationic lipoplexes : characterization in cell culture in vitro and in vivo.
Alisha. Sewbalas (2010)
10.1002/0471266949.BMC073
Plasmid DNA–Mediated Gene Therapy
Rajkumar Banerjee (2003)
Formulaciones biofarmacéuticas de ácidos desoxiribonucléicos en liposomas
E. Pupo ()
10.1038/sj.gt.3301861
Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver
L. Liu (2003)
10.1248/BPB.29.1521
Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration.
Y. Higuchi (2006)
Drug delivery systems based on sugar-macromolecule conjugates.
B. Davis (2002)
10.1074/jbc.M302232200
The Role of Organ Vascularization and Lipoplex-Serum Initial Contact in Intravenous Murine Lipofection*
D. Simberg (2003)
10.7567/JJAP.53.036701
Local electroporation of a single cell using a scanning ion conductance microscope
F. Iwata (2014)
10.1016/j.ejps.2013.06.012
Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake.
M. Elmowafy (2013)
10.7567/JJAP.54.08LB04
Development of a single cell electroporation method using a scanning ion conductance microscope with a theta nanopipette
S. Sakurai (2015)
10.1016/J.BIOS.2004.08.023
A molecular delivery system by using AFM and nanoneedle.
S. W. Han (2005)
10.1080/08982100600992443
Liposome Vector Containing Biosurfactant-Complexed DNA as Herpes Simplex Virus Thymidine Kinase Gene Delivery System
Y. Maitani (2006)
10.1007/978-1-4020-5041-1_9
Synthetic Vectors for Genetic Drug Delivery
P. Wyrozumska (2006)
10.1211/0022357021778817
Cytotoxicity issues pertinent to lipoplex‐mediated gene therapy in‐vivo
C. Dass (2002)
10.1002/0471266949.BMC073.PUB2
Gene Therapy with Plasmid DNA
S. R. Bathula (2010)
10.1081/DDC-120021771
Double Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats
Ken Katayama (2003)
Targeted cationic liposomes, technologies, and developments
Anas El-Aneed (2003)
10.2217/nnm.15.58
Carbohydrate-based materials for targeted delivery of drugs and genes to the liver.
M. Ahmed (2015)
10.3748/WJG.V10.I4.531
Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.
Xun Sun (2004)
10.1201/9780849350610-12
Liposomes: Design and Manufacturing
S. Patil (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar